top of page

$5.5 Million EBITDA Lab in the Northeast

Listing Code:

XYLAB1B

State:

Not Disclosed

Category:

Medical Labs

Asking Price:

$50,000,000

Revenue:

$15,000,000

XYLAB1B

UNDER LOI 

Company Overview 

PRIME exits and American HealthCare Capital is pleased to introduce a highly profitable, full-service, CLIA-certified medical clinical laboratory for sale that is licensed in all 50 states including the State of New York. They offer a wide array of custom solutions and services, from basic tests and preventive screenings to new innovative platforms that involve the latest technology. Financial Overview 


This Northeast business for sale is over 5 years old and has experienced consistent year-over-year growth. In 2019, they generated $8.3 million in revenue and $1.5 million in EBITDA. In 2020, they generated $11 million in revenue and $4.1 million in EBITDA. In 2021, they generated $15.1 million in revenue and $5.4 million in EBITDA. They’re on track to generate $5.5M in EBITDA in 2022 and are projecting $8.5M in EBITDA in 2023 based on opening 2 new service lines and onboarding 10 new sales reps. Asking Price The asking price for this business for sale in the Northeast is $50 million. The owner is open to a partial earn-out.

Inquire About This Listing:

In order to learn more about our listing, you must:

1. Complete a Buyer Profile:

This profile will be used to pre-qualify buyers and determine whether we can share additional details about our listings. If you have already completed a Buyer Profile, disregard.

YOU ONLY NEED TO COMPLETE A BUYER PROFILE ONCE. 

2. Sign NDA with Listing Code:

To learn more about this listing, you must sign an NDA. When completing the NDA, you will need to copy the exact LISTING CODE and LISTING TITLE.

Listing Code:

XYLAB1B

Listing Title:

$5.5 Million EBITDA Lab in the Northeast

Heading 4

Contact the Team

Jack Eskenazi President American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

bottom of page